Norsaline-p Nasal Spray 30 ml is primarily indicated in conditions like Dehydration, Electrolyte disorder, Hyponatraemia, Leg cramps, Sodium depletion, and can also be given in adjunctive therapy as an alternative drug of choice in Diabetic ketoacidosis, Poisoning.
Norsaline-p Nasal Spray 30 ml is contraindicated in conditions like Hypertension,lschaemic heart disease,Liver cirrhosis,Nephrotic syndrome,Congestive heart failure.
The signs and symptoms that are produced after the acute overdosage of Norsaline-p Nasal Spray 30 ml include Nausea, Vomiting, Diarrhea, Hemorrhage, Disseminated intravascular coagulopathy. The symptomatic adverse reactions produced by Norsaline-p Nasal Spray 30 ml are more or less tolerable and if they become severe, they can be treated symptomatically, these include Thrombophlebitis, Hypernatremia, Fluid overload.
Norsaline-p Nasal Spray 30 ml should be used with caution in the presence of CHF (congestive heart failure), circulatory insufficiency, kidney dysfunction, hypertension, peripheral edema or hypoproteinemia. When sodium supplements are administered by mouth, adequate water intake should be maintained. Sustained release tablets should not be administered to patients with gastrointestinal disorders, because of the risk of obstruction.